179 related articles for article (PubMed ID: 25048475)
1. LRIG1 enhances chemosensitivity by modulating BCL-2 expression and receptor tyrosine kinase signaling in glioma cells.
Guo Z; Chen Q; Liu B; Tian D; Zhang S; Li M
Yonsei Med J; 2014 Sep; 55(5):1196-205. PubMed ID: 25048475
[TBL] [Abstract][Full Text] [Related]
2. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
[TBL] [Abstract][Full Text] [Related]
3. LRIG1 improves chemosensitivity through inhibition of BCL-2 and MnSOD in glioblastoma.
Ding J; Liu B; He Y; Yuan X; Tian D; Ji B; Wang L; Wu L; Dong H; Wang J; Zhu X; Cai Q; Zhang S; Chen Q
Cell Biochem Biophys; 2015 Jan; 71(1):27-33. PubMed ID: 25449296
[TBL] [Abstract][Full Text] [Related]
4. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.
Zhou L; Li X; Zhou F; Jin Z; Chen D; Wang P; Zhang S; Zhuge Y; Shang Y; Zou X
Cancer Sci; 2018 Apr; 109(4):1044-1054. PubMed ID: 29450946
[TBL] [Abstract][Full Text] [Related]
6. LRIG1 enhances cisplatin sensitivity of glioma cell lines.
Wang X; Xiao Q; Xing X; Tian C; Zhang H; Ye F; Wan F; Wang B; Guo D; Lei T
Oncol Res; 2012; 20(5-6):205-11. PubMed ID: 23581227
[TBL] [Abstract][Full Text] [Related]
7. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S
Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin.
Yan Z; Jiang J; Li F; Yang W; Xie G; Zhou C; Xia S; Cheng Y
Oncol Rep; 2015 Apr; 33(4):1791-8. PubMed ID: 25695283
[TBL] [Abstract][Full Text] [Related]
9. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
10. LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.
Yang JA; Liu BH; Shao LM; Guo ZT; Yang Q; Wu LQ; Ji BW; Zhu XN; Zhang SQ; Li CJ; Chen QX
Int J Clin Exp Pathol; 2015; 8(4):3580-90. PubMed ID: 26097540
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits glioma cell growth via targeting LRIG1.
Liu L; Zhang Y; Zhu K; Song L; Tao M; Huang P; Pan Y
J BUON; 2018; 23(2):403-409. PubMed ID: 29745084
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.
Ye F; Gao Q; Xu T; Zeng L; Ou Y; Mao F; Wang H; He Y; Wang B; Yang Z; Guo D; Lei T
J Neurooncol; 2009 Sep; 94(2):183-94. PubMed ID: 19300910
[TBL] [Abstract][Full Text] [Related]
14. Effects of RNAi-mediated gene silencing of LRIG1 on proliferation and invasion of glioma cells.
Mao F; Wang B; Xi G; Sun W; Zhang H; Ye F; Guo D; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):227-232. PubMed ID: 22528225
[TBL] [Abstract][Full Text] [Related]
15. LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling.
Bai L; McEachern D; Yang CY; Lu J; Sun H; Wang S
Cancer Res; 2012 Mar; 72(5):1229-38. PubMed ID: 22241084
[TBL] [Abstract][Full Text] [Related]
16. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
[TBL] [Abstract][Full Text] [Related]
17. A role for LRIG1 in the regulation of malignant glioma aggressiveness.
Mao F; Wang B; Xiao Q; Xi G; Sun W; Zhang H; Ye F; Wan F; Guo D; Lei T; Chen X
Int J Oncol; 2013 Mar; 42(3):1081-7. PubMed ID: 23337938
[TBL] [Abstract][Full Text] [Related]
18. Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1.
Fan H; Yuan R; Cheng S; Xiong K; Zhu X; Zhang Y
Biomed Pharmacother; 2018 Jan; 97():1554-1563. PubMed ID: 29793318
[TBL] [Abstract][Full Text] [Related]
19. Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1.
Yi W; Holmlund C; Nilsson J; Inui S; Lei T; Itami S; Henriksson R; Hedman H
Exp Cell Res; 2011 Feb; 317(4):504-12. PubMed ID: 21087604
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation.
Xie R; Yang H; Xiao Q; Mao F; Zhang S; Ye F; Wan F; Wang B; Lei T; Guo D
Oncol Rep; 2013 Jan; 29(1):177-84. PubMed ID: 23124613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
